Literature DB >> 22235134

Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region.

Mauricio Budini1, Emanuele Buratti, Cristiana Stuani, Corrado Guarnaccia, Valentina Romano, Laura De Conti, Francisco E Baralle.   

Abstract

TDP-43 is one of the major components of the neuronal and glial inclusions observed in several neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration. These characteristic aggregates are a "landmark" of the disease, but their role in the pathogenesis is still obscure. In previous works, we have shown that the C-terminal Gln/Asn-rich region (residues 321-366) of TDP-43 is involved in the interaction of this protein with other members of the heterogeneous nuclear ribonucleoprotein protein family. Furthermore, we have shown that the interaction through this region is important for TDP-43 splicing inhibition of cystic fibrosis transmembrane regulator exon 9, and there were indications that it was involved in the aggregation process. Our experiments show that in cell lines and primary rat neuronal cultures, the introduction of tandem repeats carrying the 331-369-residue Gln/Asn region from TDP-43 can trigger the formation of phosphorylated and ubiquitinated aggregates that recapitulate many but not all the characteristics observed in patients. These results establish a much needed cell-based TDP-43 aggregation model useful to investigate the mechanisms involved in the formation of inclusions and the gain- and loss-of-function consequences of TDP-43 aggregation within cells. In addition, it will be a powerful tool to test novel therapeutic strategies/effectors aimed at preventing/reducing this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22235134      PMCID: PMC3293573          DOI: 10.1074/jbc.M111.288720

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  83 in total

1.  Stress granule assembly is mediated by prion-like aggregation of TIA-1.

Authors:  Natalie Gilks; Nancy Kedersha; Maranatha Ayodele; Lily Shen; Georg Stoecklin; Laura M Dember; Paul Anderson
Journal:  Mol Biol Cell       Date:  2004-09-15       Impact factor: 4.138

Review 2.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

3.  Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy.

Authors:  Nicole F Liachko; Chris R Guthrie; Brian C Kraemer
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

Review 4.  RNA-binding proteins with prion-like domains in ALS and FTLD-U.

Authors:  Aaron D Gitler; James Shorter
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

Review 5.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

Review 6.  TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.

Authors:  Todd J Cohen; Virginia M Y Lee; John Q Trojanowski
Journal:  Trends Mol Med       Date:  2011-07-23       Impact factor: 11.951

7.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

8.  Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.

Authors:  E Buratti; F E Baralle
Journal:  J Biol Chem       Date:  2001-07-24       Impact factor: 5.157

9.  Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo.

Authors:  Andrea D'Ambrogio; Emanuele Buratti; Cristiana Stuani; Corrado Guarnaccia; Maurizio Romano; Youhna M Ayala; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2009-05-08       Impact factor: 16.971

10.  Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function.

Authors:  Youhna M Ayala; Sergio Pantano; Andrea D'Ambrogio; Emanuele Buratti; Antonia Brindisi; Caterina Marchetti; Maurizio Romano; Francisco E Baralle
Journal:  J Mol Biol       Date:  2005-05-06       Impact factor: 5.469

View more
  50 in total

Review 1.  Synaptic control of local translation: the plot thickens with new characters.

Authors:  María Gabriela Thomas; Malena Lucía Pascual; Darío Maschi; Luciana Luchelli; Graciela Lidia Boccaccio
Journal:  Cell Mol Life Sci       Date:  2013-11-10       Impact factor: 9.261

2.  The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function.

Authors:  Valentina Romano; Zainuddin Quadri; Francisco E Baralle; Emanuele Buratti
Journal:  Prion       Date:  2015       Impact factor: 3.931

3.  Dysregulation of TDP-43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant.

Authors:  Kathy Newell; Francesca Paron; Miguel Mompean; Jill Murrell; Elisa Salis; Cristiana Stuani; Gary Pattee; Maurizio Romano; Douglas Laurents; Bernardino Ghetti; Emanuele Buratti
Journal:  Brain Pathol       Date:  2018-12-27       Impact factor: 6.508

4.  TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues.

Authors:  Hao-Ru Li; Wan-Chin Chiang; Po-Chun Chou; Won-Jing Wang; Jie-Rong Huang
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

5.  Functional genomic screen of human stem cell differentiation reveals pathways involved in neurodevelopment and neurodegeneration.

Authors:  Ying Zhang; Vincent P Schulz; Brian D Reed; Zheng Wang; Xinghua Pan; Jessica Mariani; Ghia Euskirchen; Michael P Snyder; Flora M Vaccarino; Natalia Ivanova; Sherman M Weissman; Anna M Szekely
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205

6.  Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.

Authors:  Miguel Mompeán; Valentina Romano; David Pantoja-Uceda; Cristiana Stuani; Francisco E Baralle; Emanuele Buratti; Douglas V Laurents
Journal:  J Biol Chem       Date:  2017-05-31       Impact factor: 5.157

7.  Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion.

Authors:  Lei-Lei Jiang; Mei-Xia Che; Jian Zhao; Chen-Jie Zhou; Mu-Yun Xie; Hai-Yin Li; Jian-Hua He; Hong-Yu Hu
Journal:  J Biol Chem       Date:  2013-05-20       Impact factor: 5.157

8.  Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis.

Authors:  Robert D Dayton; Michael A Gitcho; Elysse A Orchard; Jon D Wilson; David B Wang; Cooper D Cain; Jeffrey A Johnson; Yong-Jie Zhang; Leonard Petrucelli; J Michael Mathis; Ronald L Klein
Journal:  Mol Ther       Date:  2013-05-21       Impact factor: 11.454

9.  Exosome secretion is a key pathway for clearance of pathological TDP-43.

Authors:  Yohei Iguchi; Lara Eid; Martin Parent; Geneviève Soucy; Christine Bareil; Yuichi Riku; Kaori Kawai; Shinnosuke Takagi; Mari Yoshida; Masahisa Katsuno; Gen Sobue; Jean-Pierre Julien
Journal:  Brain       Date:  2016-09-27       Impact factor: 13.501

10.  Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones.

Authors:  Maria Udan-Johns; Rocio Bengoechea; Shaughn Bell; Jieya Shao; Marc I Diamond; Heather L True; Conrad C Weihl; Robert H Baloh
Journal:  Hum Mol Genet       Date:  2013-08-19       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.